₹ 243.55
-8.40 (-3.33%)
BSE
S
Samrat Pharmachem
₹ 243.55
BSE
SAMRATPH Fundamentals
Company Valuation
Market Cap (₹ Cr.)
75
PE Ratio
-23.50
PB Ratio
1.14
Dividend Yield
0.40%
ROE
9.91%
ROCE
14.69%
Book Value (₹)
220.67
Face Value (₹)
10.00
Analyse SAMRATPH with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 49.09% | 49.09% | 49.09% | 49.09% | 49.09% |
| Domestic Institutional Investors (DII) | 3.24% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 3.24% | 3.24% | 3.24% | 3.24% |
| Public Investors | 41.64% | 41.73% | 41.50% | 41.75% | 41.51% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
SAMRATPH Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
530125
NSE Scrip Name
SAMRATPH
ISIN
INE103E01016



